CTRI/2020/06/025597尚未招募未知
Cytological expression of hTERT, CD56, HBME-1 in thyroid neoplasms
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.New cases of thyroid masses reported as Bethesda III-VI.
- •2.Cases of thyroid masses reported as definitely Benign lesions (Bethesda II).
排除标准
- •1.Cases of thyroid masses who have received previous radio or chemo therapy.
- •2.Cases of thyroid masses who have received previous treatment for hyper- or hypothyroidism.
研究者
相似试验
进行中（未招募）
不适用
ongitudinal analysis of HBV-specific T cell responses in patients with HBeAg-negative chronic hepatitis B (CHB) treated with pegylated interferon alfa-2a (40 KD) (PEGASYS, Ro 25-8310). Immunology sub-study for a selected subgroup of patients participating in study ML 18253chronic hepatitis B, HBeAg-negativeMedDRA version: 14.1Level: PTClassification code 10019731Term: Hepatitis BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2005-000336-25-ITROCHE
招募中
不适用
Clinical trial of autologous tumor-specific T cellsNeoplasmsKCT0004064CC Hospital24
已完成
1 期
Epstein-Barr Virus (EBV) -specific T cells as therapy for relapsed / refractory EBV-positive lymphomasRelapsed or refractory EBV-positive lymphomaBlood - Haematological diseasesACTRN12608000521325Queensland Institute of Medical Research (QIMR)20
招募中
不适用
Analysis of tumor-associated antigen expressions and immune responses using clinical samplesmalignant tumors, healthy volunteersJPRN-UMIN000032851Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine120
尚未招募
不适用
Study on Cytokines in Type 1 Leprosy ReactionsCTRI/2022/03/041539ABVIMS and Dr RML Hospital